- Nasal spray vaccine based on soluble nano-spheres with synthetic corona proteins - No use of mRNA or vector technology - Better and direct immunization of mucosa against multiple
/PRNewswire/ Intravacc, a global leader in translational research and development of therapeutic vaccines and vaccines against infectious diseases, today.
/PRNewswire/ Intravacc, a global leader in translational research and development of therapeutic vaccines and vaccines against infectious diseases, today.
Nasal spray vaccine based on soluble nano-spheres with synthetic corona proteinsNo use of mRNA or vector technologyBetter and direct immunization of mucosa against multiple corona virusesIntravacc focuses
Leiden University Medical Center and Intravacc to Start Clinical Trial with New Intranasal Corona Vaccine phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.